Home LiteratureArticle Details
PMID: 25064568 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S.

e-Driver: a novel method to identify protein regions driving cancer.

Bioinformatics (Oxford, England) ·Vol. 30 ·No. 21 ·2014-11-01 ·Pages 3109-14

Porta-Pardo E, Godzik A

Abstract

Most approaches used to identify cancer driver genes focus, true to their name, on entire genes and assume that a gene, treated as one entity, has a specific role in cancer. This approach may be correct to describe effects of gene loss or changes in gene expression; however, mutations may have different effects, including their relevance to cancer, depending on which region of the gene they affect. Except for rare and well-known exceptions, there are not enough data for reliable statistics for individual positions, but an intermediate level of analysis, between an individual position and the entire gene, may give us better statistics than the former and better resolution than the latter approach. We have developed e-Driver, a method that exploits the internal distribution of somatic missense mutations between the protein's functional regions (domains or intrinsically disordered regions) to find those that show a bias in their mutation rate as compared with other regions of the same protein, providing evidence of positive selection and suggesting that these proteins may be actual cancer drivers. We have applied e-Driver to a large cancer genome dataset from The Cancer Genome Atlas and compared its performance with that of four other methods, showing that e-Driver identifies novel candidate cancer drivers and, because of its increased resolution, provides deeper insights into the potential mechanism of cancer driver genes identified by other methods. A Perl script with e-Driver and the files to reproduce the results described here can be downloaded from https://github.com/eduardporta/e-Driver.git.

MeSH Terms
Genes, Neoplasm Genomics/methods Humans Mutation Rate Mutation, Missense Neoplasm Proteins/genetics Neoplasms/genetics Software
Chemicals
Neoplasm Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Porta-Pardo Eduard
Bioinformatics and Systems Biology Program, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
Godzik Adam
Bioinformatics and Systems Biology Program, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
References (21)
21 references, click to expand
  1. AIDA: ab initio domain assembly server.
    Nucleic Acids Res. 2014 Jul;42(Web Server issue):W308-13 PMID: 24831546
  2. Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.
    Cancer Discov. 2012 May;2(5):458-71 PMID: 22588883
  3. Comprehensive identification of mutational cancer driver genes across 12 tumor types.
    Sci Rep. 2013 Oct 02;3:2650 PMID: 24084849
  4. Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers.
    Mol Syst Biol. 2013;9:637 PMID: 23340843
  5. DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes.
    Nat Biotechnol. 2011 Nov 20;29(12):1103-8 PMID: 22101487
  6. Functional impact bias reveals cancer drivers.
    Nucleic Acids Res. 2012 Nov;40(21):e169 PMID: 22904074
  7. Edgetic perturbation models of human inherited disorders.
    Mol Syst Biol. 2009;5:321 PMID: 19888216
  8. Discovery and saturation analysis of cancer genes across 21 tumour types.
    Nature. 2014 Jan 23;505(7484):495-501 PMID: 24390350
  9. Emerging landscape of oncogenic signatures across human cancers.
    Nat Genet. 2013 Oct;45(10):1127-33 PMID: 24071851
  10. International network of cancer genome projects.
    Nature. 2010 Apr 15;464(7291):993-8 PMID: 20393554
  11. The mutational landscape of phosphorylation signaling in cancer.
    Sci Rep. 2013 Oct 02;3:2651 PMID: 24089029
  12. FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded.
    Bioinformatics. 2005 Aug 15;21(16):3435-8 PMID: 15955783
  13. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes.
    Bioinformatics. 2013 Sep 15;29(18):2238-44 PMID: 23884480
  14. IDH1 and IDH2 mutations in gliomas.
    N Engl J Med. 2009 Feb 19;360(8):765-73 PMID: 19228619
  15. MuSiC: identifying mutational significance in cancer genomes.
    Genome Res. 2012 Aug;22(8):1589-98 PMID: 22759861
  16. Three-dimensional reconstruction of protein networks provides insight into human genetic disease.
    Nat Biotechnol. 2012 Jan 15;30(2):159-64 PMID: 22252508
  17. A census of human cancer genes.
    Nat Rev Cancer. 2004 Mar;4(3):177-83 PMID: 14993899
  18. The Cancer Genome Atlas Pan-Cancer analysis project.
    Nat Genet. 2013 Oct;45(10):1113-20 PMID: 24071849
  19. The Pfam protein families database.
    Nucleic Acids Res. 2012 Jan;40(Database issue):D290-301 PMID: 22127870
  20. Mutational landscape and significance across 12 major cancer types.
    Nature. 2013 Oct 17;502(7471):333-339 PMID: 24132290
  21. Flexible nets. The roles of intrinsic disorder in protein interaction networks.
    FEBS J. 2005 Oct;272(20):5129-48 PMID: 16218947
Article Info
Journal
Bioinformatics (Oxford, England)
Abbr.
Bioinformatics
ISSN
1367-4811
Published
2014-11-01
Epub
2014-00-26
Pages
3109-14
Language
English
Region
England
NLM ID
9808944
PMCID
PMC4609017
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com